Shreegluco Biotech Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 44.81 Cr
as on 16-06-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 287.86 Cr
as on 16-06-2024
- Satisfied Charges ₹ 34.54 Cr
as on 16-06-2024
- Revenue 173.12%
(FY 2023)
- Profit -20.12%
(FY 2023)
- Ebitda -8.39%
(FY 2023)
- Net Worth 23.24%
(FY 2023)
- Total Assets 41.07%
(FY 2023)
About Shreegluco Biotech
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 44.81 Cr.
The company currently has active open charges totaling ₹287.86 Cr. The company has closed loans amounting to ₹34.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Shreegluco Biotech Private Limited India is Sneha Gidwani as COMPANY SECRETARY. Aishwarya Bysani, Bysani Sanjana, Bysani Srinath, and One other member serve as directors at the Company.
- CIN/LLPIN
U15410KA2012PTC062704
- Company No.
062704
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore South, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Shreegluco Biotech Private Limited offer?
Shreegluco Biotech Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Stabilizer, Natural Sweetener, Starch Powder, Bird Food, Poultry & Animal Food, Animal Feed.
Who are the key members and board of directors at Shreegluco Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sneha Gidwani | Company Secretary | 28-Jun-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aishwarya Bysani  | Director | 31-Mar-2022 | Current |
| Bysani Sanjana | Additional Director | 04-Apr-2023 | Current |
| Bysani Srinath | Director | 24-Feb-2012 | Current |
| Bysani Mamatha | Director | 24-Feb-2012 | Current |
Financial Performance and Corporate Structure Insights of Shreegluco Biotech.
Shreegluco Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 173.12% increase. The company also saw a substantial fall in profitability, with a 20.12% decrease in profit. The company's net worth Soared by an impressive increase of 23.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shreegluco Biotech?
In 2023, Shreegluco Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adi Bhumi Ventures Llp
Active
10 months 14 days Aishwarya Bysani, Bysani Sanjana and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Jul 2022 | ₹1.18 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Apr 2022 | ₹6.71 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Apr 2022 | ₹13.43 Cr | Open |
How Many Employees Work at Shreegluco Biotech?
Shreegluco Biotech has a workforce of 341 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 31, 2021, Shreegluco Biotech has raised a total of ₹ 105.02 Cr, with the most recent deal valued at ₹ 65.03 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
